VIDEO
Dr Herbert T Nagasawa explains about
The Science of Riboceine™
RiboCeine™
Scientists and medical doctors have known for decades that
glutathione, which is produced by the body itself, is the
primary protector and detoxifier of the cell. However, under
oxidative stress conditions, the glutathione levels become
depleted. Also, from near the age of forty, the body’s ability
to produce glutathione decreases gradually, then more rapidly at
older age. For years, medical scientists have looked for ways to
effectively raise the levels of glutathione. At one time, N-acetylcysteine
(NAC) was the only supplement available to enhance the body’s
supply of cysteine to enable the production of glutathione.
However, Dr. Herbert T. Nagasawa was able to develop a
revolutionary molecule known as RiboCeine™ that effectively
delivers cysteine to the cell to support the natural production
of glutathione--for which Max International was awarded a U.S.
Patent.
Scientifically Proven and Patented Technology
RiboCeine™ is a unique molecule that combines ribose and
cysteine, nutrients that occur naturally in our bodies.
RiboCeine™ once ingested will be absorbed, enters the bloodstream
and delivers cysteine and ribose to the cells, supporting
glutathione production as well as providing ribose, an integral
part of ATP, our cells’ natural fuel and source of energy.
RiboCeine™ significantly outperformed other means of glutathione
enhancement against which it has been tested. It has been the
subject of 55 scientific studies funded by the National
Institutes of Health or other scientific funding agencies and
published in peer-reviewed journals.
Explore the wealth of
knowledge with 55 studies on RiboCeine™
Riboceine™'s distinctive
Mechanism of Action (MOA) and the profound impact on endogenous
Glutathione production. Check out the peer-reviewed and
published studies through these direct links to reputable 3rd
party research sites. Uncover the scientific validation behind
RiboCeine™, demonstrating its potential to enhance Glutathione
levels. Elevate your understanding with evidence-backed
insights.
Roberts, J.C.; Nagasawa, H.T.; Zera,
R.T.; Fricke, R.F.; Goon, D.J. W. Prodrugs
of L-cysteine as protective agents against acetaminophen-induced
hepatotoxicity. 2-(polyhydroxyalky)-and
2-(Polyacetoxyalky)-Thiazolidine-4(R)-Carboxylic Acids. J.
Med Chem. 1987, 30, 1891-1896.
Roberts, J.C.; Francetic, D.J.; Zera,
R.T. L-cysteine
prodrug protects against cyclophosphamide urotoxicity without
compromising therapeutic activity. Cancer
Chemotherapy and Pharmacology 1991, 28, 166-170.
Roberts, J.C.; Francetic, D.J. Time
course for the elevation of glutathione in numerous organs of
L1210-bearing CDF1 mice given the L-cysteine prodrug, RibCys. Toxicology
Letters, 1991, 59, 245-251.
Roberts, J.C.; Francetic, D.J.
Mechanisms of Chemoprotection by RibCys, a Thiazolidine Prodrug
of L cysteine. Med. Chem. Res., 1991, 1, 213-219.
Roberts, J.C.; Charyulu, R. L.; Zera,
R.T.; Nagasawa, H.T. Protection
Against Acetaminophen Hepatotoxicity by Ribose-Cysteine (RibCys). Pharmacology
& Toxicology, 1992, 70, 281-285.
Rowe, J.K.; Zera, R.T.; Madoff,
R.D.; Fink, A.S.; Roberts, J.C.; Johnston, G.R.; Freeney,
D.A.;Young, H.L.; Bubrick, M.P. Protective
Effect of RibCys Following High-Dose Irradiation of the
Rectosigmoid. Dis. Colon Rectum, 1993, 36(7),
681-687.
Roberts, J.C.; Francetic, D.J.; Zera,
R.T. Chemoprotection
against Cyclophosphamide-Induced Urotoxicity: Comparison of Nine
Thiol Protective Agents. AntiCancer Research, 1994,
14, 389-396.
Carroll, M.P.; Zera, R.T.; Roberts,
J.C.; Schlafmann, S.E.; Feeny, D.A.; Johnston, G.R.; West, M.A.;
Bubrick, M.P. Efficacy
of Radioprotective Agents in Preventing Small and Large Bowel
Radiation Injury. Dis. Colon Rectum, 1995,
38(7), 716-722.
Roberts, J.C.; Koch, K.E.; Detrick,
S.R.; Warters, R.L.; Lubec G. Thiazolidine
Prodrugs of Cysteamine and Cysteine as Radioprotective Agents. Radiation
Research, 1995, 143, 203-213.
Bantseev, V.; Bhardwaj, R.; Rathbun,
W.; Nagasawa, H.T.; Trevithick, J.R. Antioxidants
and Cataract: (Cataract Induction in Space Environment and
Application to Terrestrial Aging Cataract). Biochem.
Mol. Bio. Intl., 1997, 42, 1189-1197.
Roberts, J.C.; Phaneuf, H.L.;
Szakacs, J.G.; Zera, R.T.; Lamb, J.G.; Franklin, M.R. Differential
Chemoprotection against Acetaminophen-Induced Hepatotoxicity by
Latentiated L-Cysteines. Chem. Res. Toxicol., 1998,
11, 1274-1282.
Roberts, J.C.; Phaneuf, H.L.;
Dominick, P.K.; Wilmore, B.H.; Cassidy, P.B. Biodistribution
of [35S] – Cysteine and Cysteine Prodrugs: Potential Impact on
Chemoprotection Strategies. J. Labelled Cpd.
Radiopharm., 1999, 42, 485-495.
Lucus, A.M.; Henning G.; Dominick,
P.K.; Whiteley, H.E.; Roberts, J.C.; Cohen, S.D. Ribose
Cysteine Protects Against Acetaminophen-Induced Hepatic and
Renal Toxicity. Toxicologic Pathology, 2000,
28(5), 697-704.
Wilmore, B.H.; Cassidy, P.B.;
Warters, R.L.; Roberts, J.C. Thiazolidine
Prodrugs as Protective Agents against γ-Radiation-Induced
Toxicity and Mutagenesis in V79 Cells. J. Med.
Chem., 2001, 44(16), 2661-2666.
Lenarczyk, M.; Ueno, A.; Vannais,
D.B.; Kraemer, S.; Kronenberg, A.; Roberts, J.C.; Tatsumi, K.;
Hei, T.K.; Waldren, C.A. The
“Pro-drug” RibCys Decreases the Mutagenicity of High-LET
Radiation in Cultured Mammalian Cells. Radiation
Research, 2003, 160, 579-583.
Waldren, C.A.; Vannais, D.B.; Ueno
A.M. A
role for long-lived radicals (LLR) in radiation-induced mutation
and persistent chromosomal instability: counteraction by
Ascorbate and RibCys but not DMSO. Mutation
Research. 2004, 551:255-265.
Lucas Slitt, A.M.; Dominick, P.K.;
Roberts, J.C.; Cohen, S.D. Effect
of Ribose Cysteine Pretreatment on Hepatic and Renal
Acetaminophen Metabolite Formation and Glutathione Depletion. Basic
Clin. Pharmacol. Toxicol., 2005, 96 (6), 487-94.
Oz, H.S.; Chen, T.S.; Nagasawa, H., Comparative
efficacies of 2 cysteine prodrugs and a glutathione delivery
agent in a colitis model. Translational Research, 2007,
150(2), 122-129.
Oz, H.S. and Ebersole, J.L. Application
of Prodrugs to Inflammatory Diseases of the Gut. Molecules, 2008,
13, 452-474
Walker R.B., Everette J.D. Comparative
Reaction Rates of Various Antioxidants with ABTS Radical Cation. J.
Agric Food Chem. 2009:57:1156-1161.
Heman-Ackah, S.E.; Juhn, S.K.;
Huang, T.C.; Wiedmann, T.S. A
combination antioxidant therapy prevents age-related hearing
loss in C57BL/6 mice. Otolaryngology-Head and Neck
Surgery, 2010, 143, 429-434.
Jurkowska, H.; Uchacz, T.; Roberts,
J.; Wrobel, M. Potential
therapeutic advantage of ribose-cysteine in the inhibition of
astrocytoma cell proliferation. Amino Acids, 2011
41, 131-139.
Kader, T.; Porteous C.M.; Williams
M.J.A.; Gieseg, S.P.; McCormick, S.P.A. Ribose-cysteine
increases glutathione-based antioxidant status and reduces LDL
in human lipoprotein(a) mice. Atherosclerosis. 2014,
237, 725-733.
Saltman A.E. D-Ribose-L-cysteine
supplementation enhances wound healing in a rodent model. Am
J Surg. 2015, 210, 153-158.
Falana B, Adeleke O, Orenolu M,
Osinubi A, Oyewopo A. Effect
of D-ribose-L-cysteine on aluminum induced testicular damage in
male Sprague-Dawley rats. JBRA Assisted
Reproduction. 2017:21(2):94-100.
Joseph D.B., Olayemi O.S., Falana
B.A., Duru F.I.O. Osinubi A.A.A. D-Ribose-L-Cysteine
Maintained Testicular Integrity in Rats Model (Rattus Novergicus)
Exposed to X-Ray. Nuclear Medicine. 2017(2)4:20-26.
Ogunlade B., Osinubi A.A., Duru
F.I.O., Adelakun S.A., Ogunlade S.A., Alao A.A, Histomorphological
Response of Sulforaphane and RiboCeine on Annular
Puncture-Induced Model of Rabbits Intervertebral Disc
Degeneration. European Journal of biomedical and
Pharmaceutical Sciences. 2017(4)11:1-9.
N’guessan B.B., Amponsah S.K.,
Dugbartey G.J., Awuah K.D., Dotse E., Aning A., Kukuia K.K.E.,
Asiedu-Gyekye I.J., Appiah-Opong R. In
Vitro Antioxidant Potential and Effect of a Glutathione-Enhancer
Dietary Supplement on Selected Rat Liver Cytochrome P450 Enzyme
Activity. Evidence-Based Complementary and
Alternative Medicine. 2018:7462839:8 pages.
Awodele O, Badru W.A., Busari A.A.,
Kale O.E., Ajayi T.B., Udeh R.O. Emeka P.M. Toxicological
evaluation of therapeutic and supra-therapeutic doses of
Cellgevity on reproductive function and biochemical indices in
Wistar rats. BMC Pharmacology and Toxicology. 2018:19:68.
Cukrov D., Newman T.A.C., Leask M.,
Leeke B., Sarogni P., Patimo A., Kline A.D., Krantz I.D.,
Horsfield J.A., Musio A. Antioxidant
treatment ameliorates phenotypic features of SMC1A-mutated
Cornelia de Lange syndrome in vitro and in vivo. Human
Molecular Genetics. 2018:27:17:3002-3011.
Osinubi A.A.A, Medubi L.J., Akang
E.N., Sodiq L.K., Samuel, T.A., Kusemiju T., Osolu J., Madu D.,
Fasanmade O. A
comparison of the anti-diabetic potential of D-ribose-L-cysteine
with insulin, and oral hypoglycaemic agents on pregnant rats. Toxicology
Reports. 2018(5):832-838.
Medubi L.J., Ama C., Medubi O.O.,
Onwosu N.C., Lawal O.R., Osinubi A.A.A. D-Ribose-L-Cysteine-Rich
Supplement Attenuates Doxorubicin-Induced Impaired
Spermatogenesis, Testicular Steroidogenesis and Redox Status in
Sprague-Dawley Rats. African Journal of Biomedical
Research. 2019(22):179-185.
Emokpae O, Ben-Azu B, Ajayi AM,
Umukoro S. D-Ribose-L-Cysteine
attenuates lipopolysaccharide-induced memory deficits through
inhibition of oxidative stress, release of proinflammatory
cytokines, and nuclear factor-kappa B expression in mice. Naunyn-Schmiedeberg’s
Archives of Pharmacology. 07 January 2020.
Kader T., Porteous M., Jones G.,
Dickerhof N., Narayana V.K., Taraknath S., McCormick S.P.A. Ribose-Cysteine
protects against the development of atherosclerosis in apoE-deficient
mice. PLoS ONE 15(2): e0228415. 02 21 2020.
Emokpae O, Ben-Azu B, Ajayi AM,
Umukoro S. D-Ribose-L-Cysteine
enhances memory task, attenuates oxidative stress and
acetyl-cholinesterase activity in scopolamine amnesic mice. Drug
Dev Res. 2020;1-9
Amponsah S.K., N’guessan B.B,
Akandawen, A.A., Agboli S.Y., Danso, E.A., Opuni K.F.M., Asiedu
Gyekye I.J., Appiah-Opong, R. Effect
of Cellgevity Supplementation on Selected Rat Liver Cytochrome
P450 Enzyme Activity and Pharmacokinetic Parameters of
Carbamazepine. Evidence-Based Complementary and
Alternative Medicine. Volume 2020 (July 3), Article ID:
7956493, 8 pages.
Okoh, L., Ajayi, A.M., Ben-Azu, B.,
Akinluyi, E.T., Emokpae, O., Umukoro, S. D-Ribose-L-Cysteine
exhibits adaptogenic-like activity through inhibition of oxido-inflammatory
responses and increased neuronal caspase-3 activity in mice
exposed to unpredictable chronic mild stress. Molecular
Biology Reports. 2020 47:7709-7722.
Ogunlade, B., Gbotolorun S.C.,
Ogunlade, A.A. D-Ribose-L-Cysteine
modulates lead acetate-induced hematobiochemical alterations,
hormonal imbalance, and ovarian toxicity in adult female Wistar
rats. Drug and Chemical Toxicology. November
7, 2020; 1-8.
Ogunlade, B., Fidelis, O.P.,
Afolayan, O.O., Agie, J.A. Neurotherapeutic
and antioxidant response of D Ribose-L-Cysteine nutritional
dietary supplements on Alzheimer-type hippocampal
neurodegeneration induced by cuprizone in adult male wistar rate
model. Food and Chemical Toxicology. November
11, 2020; 1-9.
Oludare, G.O., Afolayan, G.O.,
Semidara, G.G. Potential
anti-toxic effect of d-ribose-l-cysteine supplement on the
reproductive functions of male rats administered
cyclophosphamide. J. Basic Clin Physiol Pharmacol. 2021
Feb 8.
Ojetola, A.A., Adedeji, T.G.,
Fasanmade, A.A. Changes
in antioxidants status, atherogenic index and cardiovascular
variables after prolonged doses of D-ribose-L-cysteine in male
Wistar rats. Heliyon 7 (2021) e06287.
Medubi, L.J., Nwosu, N.C., Medubi,
O.O., Lawal, O.R., Ama, C., Kusemiju, T.O., Osinubi, A.A.A. Increased
de novo glutathione production enhances sexual dysfunctions in
rats subjected to paradoxical sleep deprivation. JBRA
Assisted reproduction. September 30, 2020; 1-8.
Verrilli, A.M, Leibman, N.F.,
Hohenhaus, A.E., Mosher, B.A. Safety
and efficacy of a ribose-cysteine supplement to increase
erythrocyte glutathione concentration in healthy dogs. AJVR. 2021;
82(8). 653- 658.
Ogunlade, B., Adelakun, S.A.,
Ukwenya, V.O., Elemoso, T.T. Potentiating
response of D-Ribose-L Cysteine on Sodium arsenate-induced
hormonal imbalance, spermatogenesis impairments and
histomorphometric alterations in adult male Wistar rat. JBRA
Assisted Reproduction. 2021; 25(3): 358- 367.
Ojetola, A.A, Adeyemi, W.J., David,
U.E., Ajibade, T.O., Adejumobi O.A., Omobowale, T.O., Oyagbemi,
A.A., Fasanmade, A.A. D-ribose-L-cysteine
prevents oxidative stress and cardiometabolic syndrome in high
fructose high fat diet fed rats. J.Biopha. 2021
(142) 112017.
Akingbade G.T., Ijomone O.M., Imam
A., Aschner M., Ajao M.S. D-Ribose-l-Cysteine
Improves Glutathione Levels, Neuronal and Mitochondrial
Ultrastructural Damage, Caspase-3 and GFAP Expressions Following
Manganese-Induced Neurotoxicity. 2021 Sep 4. doi:
10.1007/s12640-021- 00404-3. pp 1-13.
Adelakun, S.A., Ogunlade, B., Iteire
K.A., Adedotun, O.A. Ameliorating
potential and fertility enhancing activities of nutritional
dietary supplementation of D-Ribose-L-Cysteine in cisplatin
induced oligoasthenoteratozoospermia and seminiferous epithelium
degeneration in adult male Sprague-Dawley rats. Metabolism
Open. 12 (2021) 100128.
Leask, M., Carleton, C., Leeke, B.,
Newman, T., Antoun, J., Farella, M., Horshield, J. RiboCeine
Rescues Auranofin-Induced Craniofacial Defects in Zebrafish. Antioxidants. 2021,
10, 1964.
Akingbade G.T., Ijomone O.M., Imam
A., Aschner M., Ajao A.S., D-Ribose-L-Cysteine
attenuates manganese-induced cognitive and motor deficit,
oxidative damage, and reactive microglia activation. Environmental
Toxicology and Pharmacology. 2022.
Ojetola, A.A. and Fasanmade, A.A. Ameliorative
potential of D-Ribose-L-Cysteine in male Wistar rats with
metabolic syndrome. FASEBJ. 2022, 35, May
2022.
Isabor, H., Ajayi, A.M., Ben-Azu,
B., Omeiza, N.A., Ademola, A.P., Umukoro, S. D-ribose-L-cysteine
reduces oxidative stress and inflammatory cytokines to mitigate
liver damage, and memory decline induced by copper sulfate in
mice. Journal of Trace Elements in Medicine and
Biology. 73 (2022) 127001.
Ogunlade, B., Gbotolorun, S.C.,
Ogunlade, A.A. D-ribose-L-cysteine
modulates lead acetate-induced hematobiochemical alternations,
hormonal imbalance, and ovarian toxicity in adult female Wistar
rats. Drug and Chemical Toxicology. 2022
45(4), 1606-1613.
Adekomi,D.A, Olajide, O.J., Adewale,
O.O., Okesina, A.A., Fatoki, J.O., Falana, B.A. Adeniyi, T.D.,
Adegoke A.A., Ojo, W.A., Alabi, S.O. D-ribose-L-Cysteine
exhibits neuroprotective activity through inhibition of
oxido-behavioral dysfunctions and modulated activities of
neurotransmitters in the cerebellum of Juvenile mice exposed to
ethanol. Drug Chem. Toxicol. 2022 June
20:1-11.
Mega, O.O., Edesiri, T.P., Victor,
E., Kingsley, N.E., Rume, R.A., Faith, F.Y., Simon, O.I.,
Oghenetega, B.O., Agbonito-Chijiokwu, E. d-ribose-
l-cysteine abrogates testicular maladaptive responses induced by
polychlorinated bisphenol intoxication in rats via activation of
the mTOR signaling pathway mediating inhibition of apoptosis,
inflammation, and oxidonitrergic flux. J. Biochem
Mol. Toxicol. 2022 July 13, e23161.
Ojetola, A.A., Asiwe, J.N., Adeyemi,
W.J., Ogundipe, D.J., Fasanmade, A.A. Dietary
Supplementation with D-Ribose-L-Cysteine Prevents Hepatic Stress
and Pro-Inflammatory Responses in Male Wistar Rats Fed a
High-Fructose High-Fat Diet. Pathophysiology 2022,
29, 631-639.
VIDEO